Cubist Systematic Strategies, LLC Nevro Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Nevro Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 104,176 shares of NVRO stock, worth $474,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,176

Previous 104,570 0.38%

Holding current value

$474,000

Previous $880,000 33.98%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.71 - $10.1 $1,855 - $3,979	-394 Reduced 0.38%	104,176 $581,000
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $1.47 Million - $2.51 Million	-184,887 Reduced 63.87%	104,570 $880,000
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $3.19 Million - $4.89 Million	235,458 Added 436.04%	289,457 $4.18 Million
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $765,705 - $1.2 Million	53,999 New	53,999 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $1.04 Million - $1.8 Million	45,808 Added 685.44%	52,491 $1.33 Million
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $5.68 Million - $7.74 Million	-188,225 Reduced 96.57%	6,683 $241,000
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $4.63 Million - $6.28 Million	127,127 Added 187.56%	194,908 $7.72 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $2,683 - $3,499	66 Added 0.1%	67,781 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $2,683 - $3,499	66 Added 0.1%	67,781 $3.16 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $275,410 - $523,651	6,742 Added 11.06%	67,715 $2.97 Million
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $3.26 Million - $5 Million	-54,305 Reduced 47.11%	60,973 $4.41 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $9.15 Million - $13.7 Million	112,842 Added 4632.27%	115,278 $9.35 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $662,935 - $1.08 Million	-6,500 Reduced 72.74%	2,436 $284,000
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $3.73 Million - $4.72 Million	-26,342 Reduced 74.67%	8,936 $1.48 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $1.65 Million - $2.27 Million	12,457 Added 54.59%	35,278 $4.92 Million
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $454,026 - $605,741	3,286 Added 16.82%	22,821 $3.95 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $666,399 - $849,923	-5,841 Reduced 23.02%	19,535 $2.72 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $2.27 Million - $3.3 Million	25,376 New	25,376 $3.03 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $1.87 Million - $3.84 Million	-26,582 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $16,657 - $25,623	-218 Reduced 0.81%	26,582 $3.12 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $1.5 Million - $2.23 Million	24,438 Added 1034.63%	26,800 $2.3 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $982,907 - $1.13 Million	-16,935 Reduced 87.76%	2,362 $153,000
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $534,966 - $943,119	-15,061 Reduced 43.84%	19,297 $1.21 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $1.05 Million - $1.67 Million	29,686 Added 635.4%	34,358 $1.34 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $202,173 - $345,048	4,572 Added 4572.0%	4,672 $266,000
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $14,476 - $18,500	-200 Reduced 66.67%	100 $8,000
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $3,403 - $4,339	49 Added 19.52%	300 $26,000
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $9,825 - $13,903	-149 Reduced 37.25%	251 $17,000
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $32,348 - $36,432	400	400 $36,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $161M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Nevro Corp Transaction History